Insider · CIK 0001856094

Borgeson Blake

CIK 0001856094 Name as filed on the most recent filing

Filed as Borgeson Blake (65)

71 transaction lines · from 65 filings · filed 2021-11-22 to 2026-08-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

71 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-04 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 97,500, disposed Open Form 4 filing 0001856094-26-000014
2026-07-07 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 158,500, disposed Open Form 4 filing 0001856094-26-000011
2026-06-02 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 110,400, disposed Open Form 4 filing 0001856094-26-000008
2026-05-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 105,600, disposed Open Form 4 filing 0001856094-26-000005
2026-04-07 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 93,000, disposed Open Form 4 filing 0001856094-26-000003
2026-03-03 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 588,200, disposed Open Form 4 filing 0001601830-26-000045
2026-02-03 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 924,000, disposed Open Form 4 filing 0001601830-26-000007
2026-01-06 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 959,200, disposed Open Form 4 filing 0001856094-26-000002
2025-12-02 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 961,400, disposed Open Form 4 filing 0001856094-25-000006
2024-11-12 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 87,457, disposed Open Form 4 filing 0001601830-24-000205
2024-10-29 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 76,926, disposed Open Form 4 filing 0001601830-24-000186
2024-10-15 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 76,326, disposed Open Form 4 filing 0001601830-24-000179
2024-10-01 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 71,150, disposed Open Form 4 filing 0001601830-24-000166
2024-09-17 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 78,333, disposed Open Form 4 filing 0001601830-24-000160
2024-09-03 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 71,718, disposed Open Form 4 filing 0001601830-24-000154
2024-08-20 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 81,532, disposed Open Form 4 filing 0001601830-24-000129
2024-08-06 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 78,083, disposed Open Form 4 filing 0001601830-24-000119
2024-07-23 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 97,041, disposed Open Form 4 filing 0001601830-24-000104
2024-07-09 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 83,735, disposed Open Form 4 filing 0001601830-24-000100
2024-06-25 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 108,806, disposed Open Form 4 filing 0001601830-24-000094
2024-06-11 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 96,763, disposed Open Form 4 filing 0001601830-24-000082
2024-05-28 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 104,943, disposed Open Form 4 filing 0001601830-24-000067
2024-05-14 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 202,934, disposed Open Form 4 filing 0001601830-24-000055
2024-04-30 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 90,964, disposed Open Form 4 filing 0001601830-24-000046
2024-04-16 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 87,725, disposed Open Form 4 filing 0001601830-24-000037
2024-04-02 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 100,942, disposed Open Form 4 filing 0001601830-24-000027
2024-03-19 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 216,423, disposed Open Form 4 filing 0001601830-24-000024
2024-03-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 241,805, disposed Open Form 4 filing 0001601830-24-000021
2024-02-20 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 2 lines 247,125, disposed Open Form 4 filing 0001209191-24-003708
2024-02-06 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 106,489, disposed Open Form 4 filing 0001209191-24-003000
2024-01-23 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 212,083, disposed Open Form 4 filing 0001209191-24-002250
2024-01-09 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 2 lines 273,202, disposed Open Form 4 filing 0001209191-24-001484
2023-12-26 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 213,144, disposed Open Form 4 filing 0001209191-23-059947
2023-12-12 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 84,693, disposed Open Form 4 filing 0001209191-23-058701
2023-11-28 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 76,918, disposed Open Form 4 filing 0001209191-23-056998
2023-11-14 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 56,151, disposed Open Form 4 filing 0001209191-23-055613
2023-10-31 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 46,864, disposed Open Form 4 filing 0001209191-23-054225
2023-10-17 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 58,483, disposed Open Form 4 filing 0001209191-23-053196
2023-10-03 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 64,778, disposed Open Form 4 filing 0001209191-23-052258
2023-09-19 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 74,278, disposed Open Form 4 filing 0001209191-23-050318
2023-09-05 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 78,136, disposed Open Form 4 filing 0001209191-23-048695
2023-08-22 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 79,181, disposed Open Form 4 filing 0001209191-23-047239
2023-08-08 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 2 lines 198,283, disposed Open Form 4 filing 0001209191-23-045330
2023-07-25 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 273,464, disposed Open Form 4 filing 0001209191-23-043579
2023-07-11 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 61,194, disposed Open Form 4 filing 0001209191-23-042225
2023-06-27 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 65,639, disposed Open Form 4 filing 0001209191-23-040206
2023-06-13 S, Open-market sale Recursion Pharmaceuticals, Inc.RXRX 154,506, disposed Open Form 4 filing 0001209191-23-037584

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 71
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Borgeson Blake, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001856094

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.